About Luna

Luna by Ablatus is a patented radiofrequency ablation technology enhanced by direct electrical current.

It offers the potential for incisionless, fertility-preserving, same-day procedures, with better outcomes and experience for patients and a more cost-effective option for health systems.

Ablatus is a spinout from the Norfolk and Norwich University Hospitals NHS Foundation Trust in the UK. We are backed by experienced angels and VC investors.

Our Mission

To revolutionise uterine health with minimally invasive and inclusive care

Our Technology

Luna is built on our patented technology, specifically designed for:

Larger and more
effective ablations
Incisionless access to the uterus
with a steerable probe
Better patient experience
and outcomes
Compatibility with existing ultrasound
systems
Cost-effective treatment for greater access

Why Luna?

Better
  • Fertility-preserving
  • Incisionless
  • More effective ablation of larger fibroids
  • Improved access to hard-to reach fibroids
  • Less discomfort using thinner & flexible probe
  • Simpler design and application, less risks of device-related adverse effects
Faster
  • Shorter procedural time
  • Quicker access to treatment via outpatient than inpatient procedures
  • Back to work within days instead of weeks as with open surgery
Cost-effective
  • Lower device and operating costs
  • Delivered in outpatient instead of inpatient setting
  • Fewer consumables
  • Compatible with common, existing ultrasound systems
  • Lower staff training requirements
Faster

Shorter procedural time
Quicker access to treatment via
outpatient than inpatient
procedures
Back to work within days instead of
weeks as with open surgery

Better

Fertility-preserving Incisionless
More effective ablation of larger
fibroids. Improved access to hard-
to reach fibroids. Less discomfort
using thinner & flexible probe
Simpler design and application.

Cost-Effective

Lower device and operating costs
Delivered in outpatient instead of inpatient setting
Fewer consumables
Compatible with common, existing ultrasound systems
Lower staff training requirements

Partners

Investors

Our Team

Interested?

Get In Touch